IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
+42.02%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$301M
AUM Growth
+$301M
(+37%)
Cap. Flow
+$25.5M
Cap. Flow
% of AUM
8.48%
Top 10 Holdings %
Top 10 Hldgs %
57.04%
Holding
59
New
3
Increased
11
Reduced
10
Closed
6
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$12.9M |
| 2 |
Exelixis
EXEL
|
$7.93M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$7.02M |
| 4 |
Gilead Sciences
GILD
|
$4.92M |
| 5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$4.84M |
Top Sells
| 1 |
Merck
MRK
|
$6.4M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$3.71M |
| 3 |
Amgen
AMGN
|
$3.24M |
| 4 |
Eli Lilly
LLY
|
$2.77M |
| 5 |
Incyte
INCY
|
$2.2M |
Sector Composition
| 1 | Healthcare | 91.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $24M | 7.98% | 434,000 +40,000 | +10% | +$2.21M |
|
2
BioMarin Pharmaceuticals
BMRN
$11.2B
| $22.7M | 7.54% | 185,584 +15,800 | +9% | +$1.93M |
|
|
3
Gilead Sciences
GILD
$140B
| $22.6M | 7.52% | 303,284 +66,000 | +28% | +$4.92M |
|
|
4
Vertex Pharmaceuticals
VRTX
$100B
| $18.5M | 6.14% | 64,822 -13,000 | -17% | -$3.71M |
|
|
IMMU
5
DELISTED
Immunomedics Inc
IMMU
| $15.3M | 5.1% | 448,000 +376,000 | +522% | +$12.9M |
|
6
PTC Therapeutics
PTCT
$3.92B
| $15.1M | 5.03% | 299,000 +30,000 | +11% | +$1.52M |
|
7
Acadia Pharmaceuticals
ACAD
$4.38B
| $14.7M | 4.89% | 305,000 -32,000 | -9% | -$1.54M |
|
8
Biogen
BIIB
$19.4B
| $13.3M | 4.43% | 51,200 +5,500 | +12% | +$1.43M |
|
9
Neurocrine Biosciences
NBIX
$13.8B
| $13.3M | 4.41% | 105,800 -1,500 | -1% | -$188K |
|
|
10
Amgen
AMGN
$155B
| $12M | 4% | 52,000 -14,000 | -21% | -$3.24M |
|
|
CCXI
11
DELISTED
ChemoCentryx, Inc.
CCXI
| $10.5M | 3.48% | 191,600 +1,600 | +0.8% | +$87.4K |
|
|
12
Exelixis
EXEL
$10.1B
| $10.3M | 3.42% | 452,534 +349,000 | +337% | +$7.93M |
|
|
ALXN
13
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $9.81M | 3.26% | 88,241 +14,600 | +20% | +$1.62M |
|
|
SGEN
14
DELISTED
Seagen Inc. Common Stock
SGEN
| $9.12M | 3.03% | 55,500 -1,400 | -2% | -$230K |
|
|
15
Incyte
INCY
$16.5B
| $7.99M | 2.66% | 78,000 -21,500 | -22% | -$2.2M |
|
16
Halozyme
HALO
$8.56B
| $7.94M | 2.64% | 307,633 | – | – |
|
|
17
Regeneron Pharmaceuticals
REGN
$61.5B
| $7.02M | 2.33% | +11,500 | New | +$7.02M |
|
|
MYOK
18
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $6.37M | 2.12% | 65,859 +50,000 | +315% | +$4.84M |
|
|
ZGNX
19
DELISTED
Zogenix, Inc.
ZGNX
| $6.17M | 2.05% | 236,832 -44,965 | -16% | -$1.17M |
|
20
Alnylam Pharmaceuticals
ALNY
$58.5B
| $5.37M | 1.79% | 36,300 +14,000 | +63% | +$2.07M |
|
|
MRTX
21
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.03M | 1.67% | 43,900 | – | – |
|
22
Sarepta Therapeutics
SRPT
$1.78B
| $3.5M | 1.16% | 21,500 -6,600 | -23% | -$1.07M |
|
|
BHVN
23
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $3.12M | 1.04% | +45,000 | New | +$3.12M |
|
24
Ionis Pharmaceuticals
IONS
$6.79B
| $2.36M | 0.79% | 39,781 -14,000 | -26% | -$832K |
|
25
Enanta Pharmaceuticals
ENTA
$180M
| $2.28M | 0.76% | 46,500 | – | – |
|